🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To Determine the Effects of Seladelpar on Normalization of Alkaline Phospha...
Status
Completed
Location
The Institute for Liver Health II LLC dba Arizona Clinical Trials; Arizona Liver Health
Start Date
2023-09-05
Trial ID
NCT06060665
Treatments Being Tested
An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Se...
Status
Active Not Recruiting
Location
Arkansas Diagnostic Center
Start Date
2017-12-12
Trial ID
NCT03301506
Treatments Being Tested
This study aims to provide comprehensive insights into the therapeutic effe...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-08
Trial ID
NCT07122206
Treatments Being Tested
A prospective, open-label, single-arm, investigator-initiated study (SELIC)...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07305363
Treatments Being Tested
The seladelpar registry will collect real-world data of patients with PBC d...
Status
Not Yet Recruiting
Location
Charité - Universitätsmedizin Berlin Med. Klinik für Gastroenterologie, Infektiologie und Rheumatologie (CBF)
Start Date
2026-04-01
Trial ID
NCT07549607
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with ...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-09-07
Trial ID
NCT06051617
Treatments Being Tested
The objectives of this study are to evaluate the effect of seladelpar treat...
Status
Terminated
Location
Sutter Pacific Medical Foundation - California Pacific Medical Center
Start Date
2019-11-12
Trial ID
NCT04024813
Treatments Being Tested
A Phase 2, Double-Blind (DB), Randomized, Placebo-Controlled Study Followed...
Status
Terminated
Location
CymaBay Research Site
Start Date
2018-04-30
Trial ID
NCT03551522
Treatments Being Tested
The Effect of Hepatic Impairment on The Pharmacokinetics of Seladelpar: An ...
Status
Completed
Location
Arizona Liver Health
Start Date
2021-11-16
Trial ID
NCT04950764
Treatments Being Tested
An 8-week, dose ranging, open label, randomized, Phase 2 study with a 44-we...
Status
Completed
Location
Institute for Liver Health
Start Date
2016-11-28
Trial ID
NCT02955602
Treatments Being Tested